A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer
Abstract Background Gene expression can be employed for the discovery of prognostic gene or multigene signatures cancer. In this study, we assessed the prognostic value of a 35-gene expression signature selected by pathway and machine learning based methods in adjuvant therapy-linked glioblastoma mu...
Main Authors: | Azeez A. Fatai, Junaid Gamieldien |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-04-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-018-4103-5 |
Similar Items
-
Prognostic Factors of Survival in Glioblastoma Multiforme Patients—A Retrospective Study
by: Georgiana Șerban, et al.
Published: (2022-10-01) -
A Case With Multicentric Glioblastoma Multiforme
by: Elif Tolgay, et al.
Published: (2008-08-01) -
Adjuvant uzatılmış temozolamid tedavisinin glioblastoma multiforme hastalarının sağkalımına etkisi
by: Berna YILDIRIM, et al.
Published: (2018-09-01) -
Glioblastoma multiforme - disease overview considering sports and neurorehabilitation
by: Monika Niedźwiedzka, et al.
Published: (2024-10-01) -
The effect of hypoxia on the secretome of human glioblastoma multiforme cells
by: T. I. Kushnir, et al.
Published: (2021-05-01)